{"gene":"SALL1","run_date":"2026-06-10T07:46:29","timeline":{"discoveries":[{"year":1998,"finding":"SALL1 (also known as HSAL1) encodes a putative C2H2 zinc-finger transcription factor; heterozygous loss-of-function mutations predicted to remove all zinc-finger DNA-binding domains cause Townes-Brocks syndrome, establishing SALL1 as a developmental transcription factor required for normal organogenesis.","method":"Genetic sequencing of TBS families; predicted protein truncation analysis","journal":"Nature genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — identified causative mutations in two independent families with vertical transmission, but molecular mechanism inferred from protein domain prediction rather than direct biochemical assay","pmids":["9425907"],"is_preprint":false},{"year":2001,"finding":"Mouse Sall1 is essential for ureteric bud invasion into the metanephric mesenchyme; homozygous Sall1 deletion results in incomplete ureteric bud outgrowth, failure of tubule formation, and mesenchyme apoptosis, while the mesenchyme retains competence for epithelial differentiation, indicating Sall1 is required for the inductive signaling step rather than downstream differentiation.","method":"Targeted gene knockout in mice; histological and in situ hybridization analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean knockout with defined cellular phenotype, replicated in subsequent studies, mechanistically placed Sall1 in mesenchyme-to-ureter inductive signaling","pmids":["11688560"],"is_preprint":false},{"year":2001,"finding":"SALL1 protein localizes to chromocenters (pericentromeric heterochromatin) and smaller heterochromatin foci in mammalian cells; it partially co-localizes with HP1/M31; it acts as a strong transcriptional repressor in mammalian cells; and it interacts with PIN2/TRF1 (a telomere-repeat-binding factor) via its non-N-terminal domains, as demonstrated by yeast two-hybrid and GST-pulldown.","method":"GFP-fusion live/epifluorescence microscopy; transcriptional reporter assay; yeast two-hybrid screen; GST pulldown","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — direct localization by imaging, transcriptional repressor activity by reporter assay, and protein–protein interaction confirmed by two orthogonal methods (Y2H + GST pulldown) in one study","pmids":["11751684"],"is_preprint":false},{"year":2002,"finding":"The N-terminus of mouse Sall1 is sufficient for potent transcriptional repression (>100-fold) and physically interacts with HDAC1, HDAC2, RbAp46/48, MTA-1, and MTA-2 (components of HDAC/chromatin remodeling complexes); HDAC inhibitor trichostatin A partially relieves repression (~3-fold); Sall1 is localized to discrete nuclear foci dependent on the N-terminal repression domain.","method":"Luciferase reporter transcriptional repression assay; co-immunoprecipitation with HDAC complex components; deletion analysis; TSA treatment; fluorescence microscopy","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — reconstituted repression activity in vitro, identified interacting complex components by Co-IP, confirmed domain requirements by deletion, multiple orthogonal methods in one study","pmids":["11836251"],"is_preprint":false},{"year":2002,"finding":"SALL1 interacts with UBE2I (the SUMO E2-conjugating enzyme, human UBC9 homolog) and SUMO-1; SALL1 is covalently modified by at least two SUMO-1 molecules in vitro in the presence of UBA2/AOS1 and UBE2I; mutation of lysine 1086 to arginine abolishes sumoylation, identifying K1086 as the primary SUMO acceptor site.","method":"Yeast two-hybrid; GST pulldown; in vitro sumoylation assay; site-directed mutagenesis","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution of SUMOylation with mutagenesis confirmation, validated by two orthogonal interaction methods (Y2H and GST pulldown)","pmids":["12200128"],"is_preprint":false},{"year":2003,"finding":"A truncated Sall1 protein (lacking zinc fingers 2–10 but retaining the N-terminal repression domain) acts as a dominant-negative or gain-of-function mutant: heterozygous mice expressing truncated Sall1 recapitulate human TBS (hearing loss, renal cystic hypoplasia, wrist bone abnormalities), while Sall1-null mice do not; truncated Sall1 physically interacts with all Sall family members and can mislocalize them.","method":"Knock-in mouse model expressing truncated Sall1; co-immunoprecipitation; phenotypic comparison with null allele","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo genetic model with defined phenotype, protein interaction confirmed by Co-IP, mechanistic distinction from null allele established by direct comparison","pmids":["12915476"],"is_preprint":false},{"year":2004,"finding":"Sall1 synergistically activates canonical Wnt signaling; this activity depends on its localization to pericentromeric heterochromatin (punctate nuclear foci) but not on direct association with β-catenin; RNAi knockdown of Sall1 reduces Wnt reporter activity; N-terminally truncated Sall1 (as found in TBS) disrupts normal Sall1 heterochromatin localization and reduces Wnt signal enhancement.","method":"Luciferase Wnt reporter assay; RNAi knockdown; subcellular localization by fluorescence microscopy; co-immunoprecipitation for β-catenin interaction","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional reporter assay plus RNAi and localization data, but single lab and mechanistic link between heterochromatin localization and Wnt activation is indirect","pmids":["15158448"],"is_preprint":false},{"year":2006,"finding":"A conserved 12-amino acid motif (RRKQXK-PXXF) in the N-terminus of Sall1 is sufficient to recruit the NuRD (nucleosome remodeling and deacetylase) corepressor complex; endogenous Sall1-NuRD complexes possess HDAC activity; single amino acid substitutions in the motif abolish NuRD binding; the same motif is present in all Sall family members and in Ebfaz, suggesting a general NuRD-recruitment mechanism.","method":"Co-immunoprecipitation of endogenous Sall1-NuRD; HDAC activity assay; single amino acid mutagenesis; peptide-based recruitment assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — endogenous complex isolated with enzymatic activity confirmed, motif defined by point mutagenesis, multiple orthogonal methods in one study","pmids":["16707490"],"is_preprint":false},{"year":2006,"finding":"The human SIX1 homeodomain transcription factor directly binds to the SALL1 promoter and transcriptionally activates SALL1 expression during kidney development; co-expression of SIX1 and Eya1 synergistically activates the SALL1 promoter; deletion of the SIX1 binding element significantly reduces promoter responsiveness.","method":"Luciferase reporter assay; electrophoretic mobility shift assay (EMSA); chromatin immunoprecipitation; transient transfection","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct DNA binding demonstrated by EMSA and ChIP, functional activation by reporter assay; single lab","pmids":["16670092"],"is_preprint":false},{"year":2006,"finding":"Sall4 and Sall1 form heterodimers; a truncated Sall1 (as produced by TBS mutations) causes mislocalization of Sall4 to heterochromatin, providing a mechanism by which SALL1 truncations can inhibit SALL4 function and potentially explain some TBS symptoms via SALL4 inhibition.","method":"Co-immunoprecipitation; fluorescence microscopy of localization; compound Sall4/Sall1 heterozygous mouse phenotyping","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — heterodimer confirmed by Co-IP, mislocalization shown by imaging; single lab","pmids":["16790473"],"is_preprint":false},{"year":2007,"finding":"Sall1 heterochromatin localization is mediated by its C-terminal double zinc finger motifs (7th–10th); a recombinant protein of the most C-terminal double zinc finger (9th–10th) binds specifically to A/T-rich sequences in vitro; Sall1 associates with A/T-rich sequences of major satellite DNA in pericentromeric heterochromatin in vivo.","method":"Deletion/mutation analysis of localization by fluorescence microscopy; recombinant protein DNA-binding assay; chromatin immunoprecipitation with major satellite DNA","journal":"Genes to cells : devoted to molecular & cellular mechanisms","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro DNA binding with recombinant protein plus in vivo ChIP confirming chromatin association, domain requirements mapped by mutagenesis","pmids":["17295837"],"is_preprint":false},{"year":2007,"finding":"Sall1 directly represses the endogenous target gene Gbx2 in a NuRD-dependent fashion; the Sall1 repression motif is required for this in vivo function; protein kinase C phosphorylates serine 2 of the Sall1 repression motif, and a phosphomimetic mutation at this site disrupts NuRD recruitment and Gbx2 repression in cell culture and Xenopus embryos.","method":"Xenopus embryo microinjection with Sall1 mutants; luciferase reporter assay; in vitro PKC phosphorylation assay; phosphomimetic mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vivo embryo validation of NuRD-dependent repression of a native target gene, kinase identified by in vitro assay, phosphomimetic mutagenesis confirms regulatory mechanism; multiple orthogonal methods","pmids":["17895244"],"is_preprint":false},{"year":2009,"finding":"SALL4 represses transcription of SALL1 through recruitment of the Mi-2/NuRD complex; SALL4 immunocomplexes possess HDAC activity; SALL4 binding sites at the SALL1 promoter are co-occupied by NuRD components; SALL4 overexpression decreases SALL1 mRNA levels in 293T cells.","method":"Tandem mass spectrometry identification of SALL4-associated proteins; chromatin immunoprecipitation at SALL1 promoter; qRT-PCR; HDAC activity assay; SALL4 transgenic mouse model","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP confirms SALL4 and NuRD co-occupancy at SALL1 promoter, HDAC activity confirmed, validated in transgenic mice; single lab","pmids":["19440552"],"is_preprint":false},{"year":2009,"finding":"SALL1 (Sall1) gene transfer induces angiogenesis via transcriptional activation of VEGF-A; Sall1 overexpression increases VEGF-A mRNA and protein levels, and increases VEGF-A promoter activity; neovascularization induced by Sall1 in mouse embryoid bodies is abolished by anti-VEGF antibody; truncated Sall1 does not activate the VEGF-A promoter.","method":"Gene transfer in cornea/embryoid body; VEGF-A promoter-luciferase reporter assay; qRT-PCR; ELISA; neutralizing antibody experiment","journal":"Hypertension research : official journal of the Japanese Society of Hypertension","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional angiogenesis assay with antibody rescue, promoter reporter assay identifies VEGF-A as direct target; single lab, moderate methods","pmids":["19942929"],"is_preprint":false},{"year":2010,"finding":"Sall1 in the metanephric mesenchyme controls ureteric bud tip Wnt patterning: in Sall1 mutants, the stalk marker Wnt9b and β-catenin target Axin2 are ectopically expressed in ureteric bud tips; ureteric bud arrest is rescued by reducing β-catenin levels; ectopic Wnt9b overexpression in the ureteric bud phenocopies the branching defect, placing Sall1 upstream of canonical Wnt signaling at the bud tip.","method":"Genetic epistasis in mice; compound mutant rescue by β-catenin heterozygosity; transgenic Wnt9b overexpression; in situ hybridization for marker genes","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with rescue experiment and phenocopy by independent manipulation, establishing pathway position; multiple orthogonal genetic approaches","pmids":["20702564"],"is_preprint":false},{"year":2010,"finding":"Sall1 physically interacts with Nanog and Sox2 in embryonic stem cells; genome-wide ChIP-seq identifies 591 Sall1-bound loci, 80% of which are also Nanog targets; Sall1 positively regulates and synergizes with Nanog for gene transcription; Sall1 overexpression suppresses ectodermal and mesodermal differentiation markers during embryoid body formation.","method":"Co-immunoprecipitation; ChIP-seq; overexpression and differentiation assays in ES cells and embryoid bodies","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — protein interaction confirmed by Co-IP, genomic binding by ChIP-seq, functional role in differentiation by overexpression; single lab","pmids":["21062744"],"is_preprint":false},{"year":2014,"finding":"Sall1 acts as both a transcriptional activator and repressor in nephron progenitors: it activates progenitor-specific genes and represses differentiation genes; Sall1 co-occupies many progenitor gene loci together with Six2 and physically binds Six2; however, Sall1 does not bind the Wnt4 locus repressed by Six2, and Sall1-mediated repression is independent of DNA binding at those loci.","method":"Conditional Sall1 knockout in Six2+ progenitors; inducible Sall1 deletion; ChIP-seq; co-immunoprecipitation with Six2","journal":"Journal of the American Society of Nephrology : JASN","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-seq plus Co-IP plus conditional KO phenotype, multiple orthogonal methods establishing both activator and repressor functions and physical interaction with Six2","pmids":["24744442"],"is_preprint":false},{"year":2014,"finding":"Sall1 maintains nephron progenitor stemness by restraining premature differentiation into renal vesicles; Sall1-mutant progenitors show reduced progenitor gene expression and amplified differentiation gene expression, with ectopic differentiation and depletion of Six2+Cited1+ cap mesenchyme.","method":"Conditional Sall1 knockout; transcriptional profiling; immunofluorescence for progenitor markers","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional knockout with defined molecular phenotype by transcriptional profiling and marker analysis; single lab but multiple orthogonal readouts","pmids":["24550112"],"is_preprint":false},{"year":2015,"finding":"Sall1 in renal stromal progenitors non-cell-autonomously restricts expansion of nephron progenitors; Sall1 deletion in Foxd1+ stromal cells causes aberrant nephron progenitor expansion and cystic kidneys; Sall1 protein binds to gene loci including Decorin and Fat4 in stroma, and Decorin (which inhibits BMP-mediated nephron differentiation) is upregulated while Fat4 expression is reduced in mutant stroma.","method":"Stromal-specific conditional Sall1 knockout (Foxd1-Cre); ChIP for Decorin and Fat4 loci; gene expression analysis","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-type-specific KO establishes non-cell-autonomous function, ChIP identifies direct target loci; single lab","pmids":["26511275"],"is_preprint":false},{"year":2016,"finding":"Sall1 is required for maintaining microglia as resting tissue macrophages; inducible inactivation of Sall1 in vivo converts microglia into inflammatory phagocytes, alters neurogenesis, and disturbs tissue homeostasis; Sall1 is expressed exclusively by microglia and not by other mononuclear phagocytes or CNS-resident cells.","method":"Microglia-specific inducible Sall1 knockout mice; flow cytometry; gene expression profiling; neurogenesis assays","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — inducible cell-type-specific KO with defined inflammatory and neurogenic phenotype, replicated across multiple analyses in one study","pmids":["27776109"],"is_preprint":false},{"year":2016,"finding":"Sall1 regulates microglial morphology cell-autonomously; Sall1-deficient microglia shift from ramified to amoeboid morphology in developing retina; this morphological defect is not rescued by wild-type non-microglial cells.","method":"Conditional Sall1 knockout (Cx3cr1-Cre); bone marrow transplantation; fluorescence microscopy of microglial morphology","journal":"Glia","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO plus non-rescue experiment establishing cell autonomy; single lab","pmids":["27459098"],"is_preprint":false},{"year":2016,"finding":"Sall1 is expressed in undifferentiated cardiac progenitor cells (CPCs) giving rise to both ventricles; high Sall1 levels at mesodermal stages enhance cardiomyogenesis, while continued expression suppresses cardiac differentiation, demonstrating a stage-dependent role in regulating CPC fate.","method":"Sall1 lineage tracing; in vitro overexpression and loss-of-function in CPCs; differentiation assays","journal":"Journal of molecular and cellular cardiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain- and loss-of-function with differentiation phenotype readout; single lab, moderate method quality from abstract description","pmids":["26876450"],"is_preprint":false},{"year":2017,"finding":"Sall1 interaction with the NuRD complex (via the Sall1 repression motif, SRM) is required for normal renal progenitor differentiation and loop of Henle formation; disruption of Sall1-NuRD in knock-in mice (ΔSRM) causes accelerated nephron progenitor differentiation, bilateral renal hypoplasia, and specific loss of loop of Henle/distal tubule gene expression.","method":"Sall1 ΔSRM knock-in mice; transcriptional profiling; immunohistochemistry for nephron segment markers","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo knock-in of interaction-deficient allele with defined molecular and morphological phenotype; establishes Sall1-NuRD interaction as specifically required for loop of Henle formation","pmids":["28760814"],"is_preprint":false},{"year":2018,"finding":"SALL1 functions as a tumor suppressor in breast cancer by recruiting the NuRD complex, which promotes cancer cell senescence; this tumor suppressive function involves the p38 MAPK, ERK1/2, and mTOR signaling pathways; SALL1 knockdown promotes cancer cell growth, proliferation, and colony formation.","method":"Gain- and loss-of-function in breast cancer cell lines; in vivo breast tumor models; Co-IP for NuRD recruitment; pathway inhibitor assays","journal":"Molecular cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — NuRD recruitment confirmed by Co-IP, pathway involvement by inhibitor studies, in vivo validation; single lab","pmids":["29625565"],"is_preprint":false},{"year":2018,"finding":"Truncated SALL1 (as produced by TBS mutations) interacts with cilia-related factors CCP110 and CEP97 (negative regulators of ciliogenesis) via proximity proteomics; TBS-derived fibroblasts and CRISPR-generated TBS model cells show more frequent cilia formation, altered cilia length and disassembly rates, and aberrant SHH signaling.","method":"Proximity proteomics (BioID) with truncated SALL1; CRISPR/Cas9-generated model cell line; cilia formation/length assay; SHH signaling reporter assay; TBS patient fibroblasts","journal":"American journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — proximity proteomics identifies interaction with cilia factors, functional cilia defects confirmed in multiple cell models; single lab","pmids":["29395072"],"is_preprint":false},{"year":2020,"finding":"SALL1 directly regulates commitment of odontoblast lineages by physically interacting with RUNX2 and remodeling open chromatin regions near Tgf-β2 and within the Runx2 locus; Sall1 knockdown inhibits odontoblastic differentiation and decreases chromatin accessibility at odontoblast lineage-related loci.","method":"RNA-seq; ATAC-seq; co-immunoprecipitation; proximity ligation assay; siRNA knockdown","journal":"Stem cells (Dayton, Ohio)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — protein–protein interaction with RUNX2 confirmed by Co-IP and PLA, chromatin remodeling function established by ATAC-seq; single lab","pmids":["33159702"],"is_preprint":false},{"year":2022,"finding":"SALL1 is required for the early developmental transition of embryonic microglia; microglial-specific Sall1 deletion in mice results in prolonged expression of CD206 (normally downregulated between E12.5 and E13.5) and persistence of less-ramified morphology into postnatal stages, establishing SALL1 as a transcriptional regulator of early microglial maturation.","method":"Microglial-specific conditional Sall1 knockout; immunofluorescence for CD206 and morphological analysis across developmental stages","journal":"Glia","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-type-specific conditional KO with defined developmental phenotype; single lab","pmids":["35567352"],"is_preprint":false},{"year":2023,"finding":"SALL1 enforces microglia-specific functions of the TGFβ-SMAD4 signaling axis: SMAD4 directly binds the Sall1 super-enhancer and is required for Sall1 expression in microglia; in turn, SALL1 promotes SMAD4 binding at microglia-specific enhancers while simultaneously suppressing SMAD4 binding at enhancers of genes inappropriately activated in Sall1 enhancer-KO microglia.","method":"SALL1 ChIP-seq; Sall1 enhancer knockout mice; SMAD4 ChIP-seq in wild-type and mutant microglia; super-enhancer mapping","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genomic binding studies (ChIP-seq for both SALL1 and SMAD4) in enhancer-KO model, establishing reciprocal functional interaction; multiple orthogonal approaches","pmids":["37322178"],"is_preprint":false},{"year":2006,"finding":"SALL1 contains two repression domains: one at the extreme N-terminus and one in the central region; SALL1 fragments containing the central repression domain localize to pericentromeric heterochromatin foci in NIH-3T3 cells, suggesting a link between the central repression domain and heterochromatin association.","method":"Deletion mapping with transcriptional reporter assay; fluorescence microscopy of GFP-SALL1 fragments in transfected cells","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — deletion analysis maps two repression domains and links central domain to heterochromatin localization; single lab, overlaps with Netzer 2001 findings","pmids":["16443351"],"is_preprint":false}],"current_model":"SALL1 is a multi-zinc finger transcriptional repressor that localizes to pericentromeric heterochromatin via its C-terminal zinc fingers (which bind A/T-rich satellite DNA sequences), recruits the NuRD (nucleosome remodeling and deacetylase) corepressor complex through a conserved 12-amino acid N-terminal motif (RRKQXK-PXXF), is subject to PKC-mediated phosphorylation and SUMO modification that modulate its activity, acts as an essential mesenchymal transcription factor during kidney development by controlling ureteric bud induction and nephron progenitor self-renewal, maintains microglial identity by enforcing microglia-specific TGFβ-SMAD4 genomic responses, and its disease-causing truncations act as dominant-negatives by retaining the NuRD-recruitment domain while losing DNA-binding zinc fingers and mislocalizing Sall family heterodimer partners."},"narrative":{"mechanistic_narrative":"SALL1 is a C2H2 multi-zinc-finger transcription factor that governs progenitor cell fate decisions in multiple developmental contexts by coupling sequence-specific chromatin association to corepressor recruitment [PMID:9425907, PMID:17295837]. Its C-terminal double zinc fingers (7th–10th) bind A/T-rich major satellite DNA and target the protein to pericentromeric heterochromatin, where it partially co-localizes with HP1 [PMID:11751684, PMID:17295837], while a conserved 12-amino-acid N-terminal motif (RRKQXK-PXXF) is sufficient to recruit the NuRD nucleosome-remodeling and deacetylase complex (HDAC1/2, RbAp46/48, MTA1/2), conferring potent transcriptional repression that is partially HDAC-dependent [PMID:11836251, PMID:16707490]. SALL1 can act as both repressor and activator depending on context: it directly represses targets such as Gbx2 in a NuRD-dependent manner [PMID:16707490], yet activates progenitor-specific genes in nephron progenitors [PMID:24744442]. NuRD recruitment is regulated by PKC phosphorylation of the repression motif, and SALL1 is also SUMOylated at K1086 [PMID:12200128, PMID:17895244]. In kidney development, SALL1 is activated downstream of SIX1/Eya1 [PMID:16670092] and is essential for ureteric bud induction, restraining ectopic Wnt9b/β-catenin signaling at the bud tip, and maintaining Six2+ nephron progenitor self-renewal while restraining premature differentiation—functions that require its physical interaction with Six2 and an intact NuRD-recruitment motif [PMID:11688560, PMID:20702564, PMID:24744442, PMID:28760814]. In the CNS, SALL1 is expressed exclusively by microglia and maintains their resting, ramified identity by enforcing microglia-specific TGFβ-SMAD4 genomic responses [PMID:27776109, PMID:37322178]. Disease-causing truncations that remove the zinc fingers but retain the NuRD-recruitment domain act as dominant-negatives, mislocalizing Sall family heterodimer partners and causing Townes-Brocks syndrome [PMID:9425907, PMID:12915476, PMID:16790473].","teleology":[{"year":1998,"claim":"Establishing the gene's identity, this work showed that heterozygous truncating SALL1 mutations cause Townes-Brocks syndrome, defining SALL1 as a zinc-finger transcription factor required for organogenesis.","evidence":"Genetic sequencing of TBS families with predicted protein truncation analysis","pmids":["9425907"],"confidence":"Medium","gaps":["Mechanism inferred from domain prediction, not biochemical assay","No direct demonstration of dominant-negative vs haploinsufficiency at this stage"]},{"year":2001,"claim":"Mouse knockout placed Sall1 in the inductive signaling step of kidney development rather than terminal differentiation, showing it is required for ureteric bud invasion of the metanephric mesenchyme.","evidence":"Targeted gene knockout in mice with histology and in situ hybridization","pmids":["11688560"],"confidence":"High","gaps":["Molecular targets mediating the inductive signal not identified","Did not address transcriptional mechanism"]},{"year":2001,"claim":"Imaging and interaction studies established SALL1 as a heterochromatin-associated transcriptional repressor, linking it to pericentromeric foci and HP1.","evidence":"GFP-fusion microscopy, reporter assays, yeast two-hybrid and GST pulldown","pmids":["11751684"],"confidence":"High","gaps":["DNA sequence specificity not defined","PIN2/TRF1 interaction functional consequence unclear"]},{"year":2002,"claim":"Biochemistry identified the molecular basis of repression: the N-terminus recruits HDAC/chromatin-remodeling complex components, with HDAC inhibition only partially relieving repression.","evidence":"Luciferase repression assays, Co-IP with HDAC complex components, deletion analysis, TSA treatment","pmids":["11836251"],"confidence":"High","gaps":["Minimal recruitment motif not yet defined","HDAC-independent repression component unexplained"]},{"year":2002,"claim":"Post-translational regulation was established by showing SALL1 is SUMOylated at a defined lysine via UBE2I, adding a modification layer to its activity.","evidence":"Yeast two-hybrid, GST pulldown, in vitro SUMOylation assay with K1086R mutagenesis","pmids":["12200128"],"confidence":"High","gaps":["Functional consequence of SUMOylation on transcription not shown","In vivo relevance not tested"]},{"year":2003,"claim":"A knock-in model resolved the disease mechanism, demonstrating that truncated Sall1 acts as a dominant-negative/gain-of-function that recapitulates TBS, distinct from the null allele, by binding and mislocalizing Sall family members.","evidence":"Truncated Sall1 knock-in mice, Co-IP, phenotypic comparison with null","pmids":["12915476"],"confidence":"High","gaps":["Specific mislocalized targets driving each phenotype not isolated","Did not map the heterodimerization interface"]},{"year":2006,"claim":"The repression machinery was pinned to a precise 12-amino-acid motif sufficient to recruit the NuRD complex with intrinsic HDAC activity, defining a general Sall-family NuRD-recruitment mechanism.","evidence":"Co-IP of endogenous Sall1-NuRD, HDAC activity assay, single-residue mutagenesis, peptide recruitment","pmids":["16707490"],"confidence":"High","gaps":["Genomic loci recruited via this motif not mapped in this study","Regulation of motif activity not addressed"]},{"year":2006,"claim":"Upstream regulation was identified, showing SIX1 (with Eya1) directly binds and activates the SALL1 promoter during kidney development.","evidence":"Reporter assay, EMSA, ChIP, transient transfection","pmids":["16670092"],"confidence":"Medium","gaps":["Single lab","In vivo requirement of the SIX1 element not tested"]},{"year":2006,"claim":"Domain mapping revealed a second, central repression domain that itself localizes to heterochromatin, refining the modular architecture of SALL1.","evidence":"Deletion mapping with reporter assay and GFP-fragment microscopy","pmids":["16443351"],"confidence":"Medium","gaps":["Mechanism of central-domain repression undefined","Overlaps with prior localization findings"]},{"year":2007,"claim":"DNA-binding specificity was established, mapping heterochromatin targeting to the C-terminal zinc fingers that bind A/T-rich satellite DNA in vitro and in vivo.","evidence":"Deletion/mutation localization analysis, recombinant DNA-binding assay, satellite-DNA ChIP","pmids":["17295837"],"confidence":"High","gaps":["Genome-wide euchromatic targets not defined here","Functional role of satellite binding unclear"]},{"year":2007,"claim":"A native target and a regulatory switch were defined: Sall1 represses Gbx2 via NuRD, and PKC phosphorylation of the motif disrupts NuRD recruitment, linking signaling to repression in vivo.","evidence":"Xenopus microinjection, reporter assays, in vitro PKC phosphorylation, phosphomimetic mutagenesis","pmids":["17895244"],"confidence":"High","gaps":["Physiological stimuli triggering PKC phosphorylation unidentified","Breadth of NuRD-dependent targets unknown"]},{"year":2009,"claim":"A regulatory feedback was revealed: SALL4 represses SALL1 by recruiting NuRD to the SALL1 promoter, embedding SALL1 in a Sall-family cross-regulatory network.","evidence":"Mass spectrometry, ChIP at SALL1 promoter, qRT-PCR, HDAC assay, transgenic mice","pmids":["19440552"],"confidence":"Medium","gaps":["Single lab","Physiological context of SALL4-SALL1 repression not established in vivo"]},{"year":2009,"claim":"An activating role in vascular biology was shown, with SALL1 transcriptionally inducing VEGF-A to drive angiogenesis, and truncated SALL1 failing to do so.","evidence":"Gene transfer angiogenesis assay, VEGF-A promoter reporter, qRT-PCR/ELISA, neutralizing antibody","pmids":["19942929"],"confidence":"Medium","gaps":["Direct SALL1 binding at VEGF-A promoter not mapped","Single lab"]},{"year":2010,"claim":"Wnt-pathway relationships were dissected: early work showed Sall1 enhances canonical Wnt signaling dependent on heterochromatin localization, while genetic epistasis placed Sall1 upstream of Wnt9b/β-catenin at the ureteric bud tip.","evidence":"Wnt reporter/RNAi/localization; mouse genetic epistasis with β-catenin rescue and Wnt9b phenocopy","pmids":["15158448","20702564"],"confidence":"High","gaps":["Direct transcriptional targets linking Sall1 to Wnt9b regulation not identified","Mechanism connecting heterochromatin localization to Wnt enhancement remains indirect"]},{"year":2010,"claim":"A pluripotency role was identified, showing Sall1 physically associates with Nanog and Sox2 and co-occupies Nanog target loci genome-wide in ES cells.","evidence":"Co-IP, ChIP-seq, overexpression/differentiation assays","pmids":["21062744"],"confidence":"Medium","gaps":["Single lab","Whether Sall1 is required (vs sufficient) for pluripotency maintenance not resolved"]},{"year":2014,"claim":"The dual repressor/activator nature of Sall1 in nephron progenitors was established, with co-occupancy and physical interaction with Six2 and DNA-binding-independent repression at key differentiation loci.","evidence":"Conditional/inducible KO, ChIP-seq, Co-IP with Six2","pmids":["24744442","24550112"],"confidence":"High","gaps":["Mechanism of DNA-binding-independent repression unresolved","How activator vs repressor mode is selected at each locus unclear"]},{"year":2015,"claim":"A non-cell-autonomous function was uncovered, showing stromal Sall1 restricts nephron progenitor expansion through regulation of Decorin and Fat4.","evidence":"Foxd1-Cre conditional KO, ChIP at target loci, expression analysis","pmids":["26511275"],"confidence":"Medium","gaps":["Single lab","Direct vs indirect regulation of secreted signals not fully separated"]},{"year":2016,"claim":"A distinct lineage role in the CNS was defined, establishing Sall1 as a microglia-restricted factor required to maintain resting tissue-macrophage identity and morphology.","evidence":"Inducible and Cx3cr1-Cre microglial KO, flow cytometry, expression profiling, bone marrow transplant","pmids":["27776109","27459098"],"confidence":"High","gaps":["Direct genomic targets in microglia not yet mapped at this stage","Mechanism enforcing identity not defined"]},{"year":2016,"claim":"A stage-dependent role in cardiac progenitors was shown, where Sall1 levels switch between promoting and suppressing cardiomyogenic differentiation.","evidence":"Lineage tracing, gain/loss-of-function differentiation assays in CPCs","pmids":["26876450"],"confidence":"Medium","gaps":["Molecular targets in CPCs unidentified","Single lab"]},{"year":2017,"claim":"The in vivo requirement of NuRD recruitment was isolated, showing the Sall1 repression motif is specifically needed for nephron progenitor differentiation timing and loop of Henle formation.","evidence":"ΔSRM knock-in mice, transcriptional profiling, segment-marker IHC","pmids":["28760814"],"confidence":"High","gaps":["Genome-wide NuRD-dependent targets in progenitors not enumerated","Why loop of Henle is selectively affected unexplained"]},{"year":2018,"claim":"A tumor-suppressor function was established, with SALL1 recruiting NuRD to promote breast cancer cell senescence through p38/ERK/mTOR signaling.","evidence":"Gain/loss-of-function in cell lines, in vivo tumor models, Co-IP, pathway inhibitors","pmids":["29625565"],"confidence":"Medium","gaps":["Single lab","Direct senescence target genes not defined"]},{"year":2018,"claim":"A non-transcriptional disease mechanism was identified, showing truncated SALL1 interacts with ciliogenesis regulators CCP110/CEP97 and perturbs cilia and SHH signaling in TBS models.","evidence":"BioID proximity proteomics, CRISPR model cells, cilia/SHH assays, patient fibroblasts","pmids":["29395072"],"confidence":"Medium","gaps":["Single lab","Whether full-length SALL1 normally regulates cilia unclear"]},{"year":2020,"claim":"A chromatin-remodeling role in odontoblast commitment was shown, with SALL1 binding RUNX2 and modulating accessibility near Tgf-β2 and the Runx2 locus.","evidence":"RNA-seq, ATAC-seq, Co-IP, proximity ligation, siRNA knockdown","pmids":["33159702"],"confidence":"Medium","gaps":["Single lab","Direct vs indirect chromatin effects not separated"]},{"year":2022,"claim":"An early microglial developmental role was defined, showing Sall1 drives the embryonic maturation transition marked by CD206 downregulation and ramification.","evidence":"Microglial conditional KO, CD206 immunofluorescence, morphology across stages","pmids":["35567352"],"confidence":"Medium","gaps":["Direct transcriptional targets of the maturation program unidentified","Single lab"]},{"year":2023,"claim":"The microglial identity mechanism was resolved, showing reciprocal control where SMAD4 activates the Sall1 super-enhancer and SALL1 in turn directs SMAD4 to microglia-specific enhancers while blocking inappropriate ones.","evidence":"SALL1 and SMAD4 ChIP-seq in enhancer-KO mice, super-enhancer mapping","pmids":["37322178"],"confidence":"High","gaps":["Whether NuRD mediates the SMAD4 redistribution not tested","Structural basis of SALL1-SMAD4 cooperation unknown"]},{"year":null,"claim":"How SALL1 selects between transcriptional activation and NuRD-dependent repression at individual loci, and how its DNA-binding-independent repression operates, remain unresolved across its developmental and immune contexts.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model for activator-vs-repressor mode selection","Mechanism of DNA-binding-independent repression undefined","Structural basis of partner heterodimerization unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,2,3,16]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[10]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[4]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[2,3]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[2,10]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[3,28]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[3,7,16]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[7,25]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[1,14,16,22]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[14,27]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[19,27]}],"complexes":["NuRD complex"],"partners":["HDAC1","HDAC2","MTA1","MTA2","SIX2","SMAD4","RUNX2","UBE2I"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9NSC2","full_name":"Sal-like protein 1","aliases":["Spalt-like transcription factor 1","Zinc finger protein 794","Zinc finger protein SALL1","Zinc finger protein Spalt-1","HSal1","Sal-1"],"length_aa":1324,"mass_kda":140.4,"function":"Transcriptional repressor involved in organogenesis. Plays an essential role in ureteric bud invasion during kidney development","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9NSC2/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SALL1","classification":"Not Classified","n_dependent_lines":12,"n_total_lines":1208,"dependency_fraction":0.009933774834437087},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"HDAC1","stoichiometry":0.2},{"gene":"HDAC2","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/SALL1","total_profiled":1310},"omim":[{"mim_id":"617466","title":"TOWNES-BROCKS SYNDROME 2; TBS2","url":"https://www.omim.org/entry/617466"},{"mim_id":"614026","title":"KINESIN FAMILY MEMBER 26B; KIF26B","url":"https://www.omim.org/entry/614026"},{"mim_id":"607343","title":"SAL-LIKE 4; SALL4","url":"https://www.omim.org/entry/607343"},{"mim_id":"607323","title":"DUANE-RADIAL RAY SYNDROME; DRRS","url":"https://www.omim.org/entry/607323"},{"mim_id":"605079","title":"SAL-LIKE 3; SALL3","url":"https://www.omim.org/entry/605079"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Nucleoli","reliability":"Additional"},{"location":"Nuclear speckles","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":28.2},{"tissue":"kidney","ntpm":31.7},{"tissue":"liver","ntpm":34.3}],"url":"https://www.proteinatlas.org/search/SALL1"},"hgnc":{"alias_symbol":["Hsal1","ZNF794"],"prev_symbol":["TBS"]},"alphafold":{"accession":"Q9NSC2","domains":[{"cath_id":"3.30.160.60","chopping":"448-515","consensus_level":"medium","plddt":79.2307,"start":448,"end":515},{"cath_id":"3.30.160.60","chopping":"706-760","consensus_level":"medium","plddt":81.5565,"start":706,"end":760},{"cath_id":"3.30.160.60","chopping":"775-789_1001-1055","consensus_level":"medium","plddt":84.5931,"start":775,"end":1055},{"cath_id":"3.30.160.60","chopping":"1132-1188","consensus_level":"medium","plddt":83.9381,"start":1132,"end":1188}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NSC2","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NSC2-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NSC2-F1-predicted_aligned_error_v6.png","plddt_mean":48.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SALL1","jax_strain_url":"https://www.jax.org/strain/search?query=SALL1"},"sequence":{"accession":"Q9NSC2","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NSC2.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NSC2/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NSC2"}},"corpus_meta":[{"pmid":"27776109","id":"PMC_27776109","title":"Sall1 is a transcriptional regulator defining microglia identity and function.","date":"2016","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27776109","citation_count":457,"is_preprint":false},{"pmid":"9425907","id":"PMC_9425907","title":"Mutations in the SALL1 putative transcription factor gene cause Townes-Brocks syndrome.","date":"1998","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9425907","citation_count":362,"is_preprint":false},{"pmid":"11688560","id":"PMC_11688560","title":"Murine homolog of SALL1 is essential for ureteric bud invasion in kidney development.","date":"2001","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11688560","citation_count":286,"is_preprint":false},{"pmid":"16790473","id":"PMC_16790473","title":"The murine homolog of SALL4, a causative gene in Okihiro syndrome, is essential for embryonic stem cell proliferation, and cooperates with Sall1 in anorectal, heart, brain and kidney development.","date":"2006","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16790473","citation_count":220,"is_preprint":false},{"pmid":"19440552","id":"PMC_19440552","title":"Stem cell factor SALL4 represses the transcriptions of PTEN and SALL1 through an epigenetic repressor complex.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19440552","citation_count":143,"is_preprint":false},{"pmid":"9973281","id":"PMC_9973281","title":"Molecular analysis of SALL1 mutations in Townes-Brocks syndrome.","date":"1999","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9973281","citation_count":143,"is_preprint":false},{"pmid":"16707490","id":"PMC_16707490","title":"A conserved 12-amino acid motif in Sall1 recruits the nucleosome remodeling and deacetylase corepressor complex.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16707490","citation_count":119,"is_preprint":false},{"pmid":"24853880","id":"PMC_24853880","title":"Utility of the trabecular bone score (TBS) in secondary osteoporosis.","date":"2014","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/24853880","citation_count":117,"is_preprint":false},{"pmid":"12915476","id":"PMC_12915476","title":"Expression of a truncated Sall1 transcriptional repressor is responsible for Townes-Brocks syndrome birth defects.","date":"2003","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12915476","citation_count":106,"is_preprint":false},{"pmid":"30723213","id":"PMC_30723213","title":"Generation of pluripotent stem cell-derived mouse kidneys in Sall1-targeted anephric rats.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30723213","citation_count":91,"is_preprint":false},{"pmid":"22941973","id":"PMC_22941973","title":"Characteristics of TBS-extractable hyperphosphorylated tau species: aggregation intermediates in rTg4510 mouse brain.","date":"2013","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/22941973","citation_count":89,"is_preprint":false},{"pmid":"11751684","id":"PMC_11751684","title":"SALL1, the gene mutated in Townes-Brocks syndrome, encodes a transcriptional repressor which interacts with TRF1/PIN2 and localizes to pericentromeric heterochromatin.","date":"2001","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11751684","citation_count":77,"is_preprint":false},{"pmid":"34112790","id":"PMC_34112790","title":"Hybrid AI-assistive diagnostic model permits rapid TBS classification of cervical liquid-based thin-layer cell smears.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34112790","citation_count":71,"is_preprint":false},{"pmid":"11836251","id":"PMC_11836251","title":"Murine Sall1 represses transcription by recruiting a histone deacetylase complex.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11836251","citation_count":69,"is_preprint":false},{"pmid":"10341258","id":"PMC_10341258","title":"GABAB receptor antagonism: facilitatory effects on memory parallel those on LTP induced by TBS but not HFS.","date":"1999","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/10341258","citation_count":69,"is_preprint":false},{"pmid":"24744442","id":"PMC_24744442","title":"Sall1 maintains nephron progenitors and nascent nephrons by acting as both an activator and a repressor.","date":"2014","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/24744442","citation_count":67,"is_preprint":false},{"pmid":"11404093","id":"PMC_11404093","title":"Embryonic expression of the murine homologue of SALL1, the gene mutated in Townes--Brocks syndrome.","date":"2001","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/11404093","citation_count":63,"is_preprint":false},{"pmid":"10533063","id":"PMC_10533063","title":"Townes-Brocks syndrome: detection of a SALL1 mutation hot spot and evidence for a position effect in one patient.","date":"1999","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/10533063","citation_count":61,"is_preprint":false},{"pmid":"37322178","id":"PMC_37322178","title":"SALL1 enforces microglia-specific DNA binding and function of SMADs to establish microglia identity.","date":"2023","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37322178","citation_count":60,"is_preprint":false},{"pmid":"30687011","id":"PMC_30687011","title":"Expression of Tmem119/Sall1 and Ccr2/CD69 in FACS-Sorted Microglia- and Monocyte/Macrophage-Enriched Cell Populations After Intracerebral Hemorrhage.","date":"2019","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30687011","citation_count":58,"is_preprint":false},{"pmid":"11102974","id":"PMC_11102974","title":"SALL1 mutations in Townes-Brocks syndrome and related disorders.","date":"2000","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/11102974","citation_count":56,"is_preprint":false},{"pmid":"21062744","id":"PMC_21062744","title":"Sall1 regulates embryonic stem cell differentiation in association with nanog.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21062744","citation_count":55,"is_preprint":false},{"pmid":"18818376","id":"PMC_18818376","title":"Sall1, sall2, and sall4 are required for neural tube closure in mice.","date":"2008","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/18818376","citation_count":55,"is_preprint":false},{"pmid":"28011742","id":"PMC_28011742","title":"The Superior Temporal Sulcus Is Causally Connected to the Amygdala: A Combined TBS-fMRI Study.","date":"2016","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28011742","citation_count":54,"is_preprint":false},{"pmid":"16088922","id":"PMC_16088922","title":"SALL1 mutation analysis in Townes-Brocks syndrome: twelve novel mutations and expansion of the phenotype.","date":"2005","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/16088922","citation_count":53,"is_preprint":false},{"pmid":"15158448","id":"PMC_15158448","title":"Sall1, a causative gene for Townes-Brocks syndrome, enhances the canonical Wnt signaling by localizing to heterochromatin.","date":"2004","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15158448","citation_count":53,"is_preprint":false},{"pmid":"24550112","id":"PMC_24550112","title":"Sall1 balances self-renewal and differentiation of renal progenitor cells.","date":"2014","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/24550112","citation_count":52,"is_preprint":false},{"pmid":"29625565","id":"PMC_29625565","title":"SALL1 functions as a tumor suppressor in breast cancer by regulating cancer cell senescence and metastasis through the NuRD complex.","date":"2018","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/29625565","citation_count":51,"is_preprint":false},{"pmid":"23391494","id":"PMC_23391494","title":"The effect of functionalizing lipid nanocapsules with NFL-TBS.40-63 peptide on their uptake by glioblastoma cells.","date":"2013","source":"Biomaterials","url":"https://pubmed.ncbi.nlm.nih.gov/23391494","citation_count":50,"is_preprint":false},{"pmid":"30291470","id":"PMC_30291470","title":"Dickkopf-1 (Dkk-1) serum levels in systemic sclerosis and rheumatoid arthritis patients: correlation with the Trabecular Bone Score (TBS).","date":"2018","source":"Clinical rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/30291470","citation_count":49,"is_preprint":false},{"pmid":"17295837","id":"PMC_17295837","title":"Mouse homolog of SALL1, a causative gene for Townes-Brocks syndrome, binds to A/T-rich sequences in pericentric heterochromatin via its C-terminal zinc finger domains.","date":"2007","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/17295837","citation_count":46,"is_preprint":false},{"pmid":"22228756","id":"PMC_22228756","title":"Sall1 regulates cortical neurogenesis and laminar fate specification in mice: implications for neural abnormalities in Townes-Brocks syndrome.","date":"2011","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/22228756","citation_count":45,"is_preprint":false},{"pmid":"17221874","id":"PMC_17221874","title":"Townes-Brocks syndrome: twenty novel SALL1 mutations in sporadic and familial cases and refinement of the SALL1 hot spot region.","date":"2007","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/17221874","citation_count":45,"is_preprint":false},{"pmid":"40311613","id":"PMC_40311613","title":"Monocytes can efficiently replace all brain macrophages and fetal liver monocytes can generate bona fide SALL1+ microglia.","date":"2025","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/40311613","citation_count":43,"is_preprint":false},{"pmid":"27459098","id":"PMC_27459098","title":"Conditional rod photoreceptor ablation reveals Sall1 as a microglial marker and regulator of microglial morphology in the retina.","date":"2016","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/27459098","citation_count":43,"is_preprint":false},{"pmid":"23562130","id":"PMC_23562130","title":"Effects of Exemestane and Tamoxifen treatment on bone texture analysis assessed by TBS in comparison with bone mineral density assessed by DXA in women with breast cancer.","date":"2013","source":"Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry","url":"https://pubmed.ncbi.nlm.nih.gov/23562130","citation_count":43,"is_preprint":false},{"pmid":"20127799","id":"PMC_20127799","title":"A mouse line expressing Sall1-driven inducible Cre recombinase in the kidney mesenchyme.","date":"2010","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/20127799","citation_count":42,"is_preprint":false},{"pmid":"39595072","id":"PMC_39595072","title":"Harnessing Brain Plasticity: The Therapeutic Power of Repetitive Transcranial Magnetic Stimulation (rTMS) and Theta Burst Stimulation (TBS) in Neurotransmitter Modulation, Receptor Dynamics, and Neuroimaging for Neurological Innovations.","date":"2024","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/39595072","citation_count":39,"is_preprint":false},{"pmid":"16670092","id":"PMC_16670092","title":"Transcriptional activation of the SALL1 by the human SIX1 homeodomain during kidney development.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16670092","citation_count":38,"is_preprint":false},{"pmid":"16429401","id":"PMC_16429401","title":"Detection of heterozygous SALL1 deletions by quantitative real time PCR proves the contribution of a SALL1 dosage effect in the pathogenesis of Townes-Brocks syndrome.","date":"2006","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/16429401","citation_count":38,"is_preprint":false},{"pmid":"17895244","id":"PMC_17895244","title":"A phosphomimetic mutation in the Sall1 repression motif disrupts recruitment of the nucleosome remodeling and deacetylase complex and repression of Gbx2.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17895244","citation_count":37,"is_preprint":false},{"pmid":"18000979","id":"PMC_18000979","title":"Nonsense-mediated decay and the molecular pathogenesis of mutations in SALL1 and GLI3.","date":"2007","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/18000979","citation_count":36,"is_preprint":false},{"pmid":"20702564","id":"PMC_20702564","title":"Sall1-dependent signals affect Wnt signaling and ureter tip fate to initiate kidney development.","date":"2010","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/20702564","citation_count":36,"is_preprint":false},{"pmid":"16221172","id":"PMC_16221172","title":"Essential roles of Sall1 in kidney development.","date":"2005","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/16221172","citation_count":35,"is_preprint":false},{"pmid":"10965108","id":"PMC_10965108","title":"Molecular cloning, chromosomal localization, and expression of the murine SALL1 ortholog Sall1.","date":"2000","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10965108","citation_count":35,"is_preprint":false},{"pmid":"11279021","id":"PMC_11279021","title":"The zinc finger domain of Tzfp binds to the tbs motif located at the upstream flanking region of the Aie1 (aurora-C) kinase gene.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11279021","citation_count":35,"is_preprint":false},{"pmid":"29395072","id":"PMC_29395072","title":"Truncated SALL1 Impedes Primary Cilia Function in Townes-Brocks Syndrome.","date":"2018","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29395072","citation_count":34,"is_preprint":false},{"pmid":"24292671","id":"PMC_24292671","title":"An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation.","date":"2013","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/24292671","citation_count":34,"is_preprint":false},{"pmid":"10654325","id":"PMC_10654325","title":"Townes-Brocks syndrome and renal dysplasia: a novel mutation in the SALL1 gene.","date":"2000","source":"Pediatric nephrology (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/10654325","citation_count":31,"is_preprint":false},{"pmid":"11484202","id":"PMC_11484202","title":"Unique family with Townes-Brocks syndrome, SALL1 mutation, and cardiac defects.","date":"2001","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11484202","citation_count":30,"is_preprint":false},{"pmid":"11478532","id":"PMC_11478532","title":"Townes-Brocks syndrome versus expanded spectrum hemifacial microsomia: review of eight patients and further evidence of a \"hot spot\" for mutation in the SALL1 gene.","date":"2001","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11478532","citation_count":27,"is_preprint":false},{"pmid":"26511275","id":"PMC_26511275","title":"Sall1 in renal stromal progenitors non-cell autonomously restricts the excessive expansion of nephron progenitors.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26511275","citation_count":27,"is_preprint":false},{"pmid":"22308078","id":"PMC_22308078","title":"Implications for genotype-phenotype predictions in Townes-Brocks syndrome: case report of a novel SALL1 deletion and review of the literature.","date":"2012","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/22308078","citation_count":27,"is_preprint":false},{"pmid":"23603097","id":"PMC_23603097","title":"The NFL-TBS.40-63 anti-glioblastoma peptide enters selectively in glioma cells by endocytosis.","date":"2013","source":"International journal of pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/23603097","citation_count":27,"is_preprint":false},{"pmid":"16443351","id":"PMC_16443351","title":"Defining the heterochromatin localization and repression domains of SALL1.","date":"2006","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/16443351","citation_count":26,"is_preprint":false},{"pmid":"26876450","id":"PMC_26876450","title":"Sall1 transiently marks undifferentiated heart precursors and regulates their fate.","date":"2016","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/26876450","citation_count":23,"is_preprint":false},{"pmid":"12065233","id":"PMC_12065233","title":"SALL1 expression in the human pituitary-adrenal/gonadal axis.","date":"2002","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/12065233","citation_count":23,"is_preprint":false},{"pmid":"29973294","id":"PMC_29973294","title":"HAM-TBS: high-accuracy methylation measurements via targeted bisulfite sequencing.","date":"2018","source":"Epigenetics & chromatin","url":"https://pubmed.ncbi.nlm.nih.gov/29973294","citation_count":22,"is_preprint":false},{"pmid":"28760814","id":"PMC_28760814","title":"A Sall1-NuRD interaction regulates multipotent nephron progenitors and is required for loop of Henle formation.","date":"2017","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/28760814","citation_count":22,"is_preprint":false},{"pmid":"23069192","id":"PMC_23069192","title":"Homozygous SALL1 mutation causes a novel multiple congenital anomaly-mental retardation syndrome.","date":"2012","source":"The Journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/23069192","citation_count":21,"is_preprint":false},{"pmid":"17431915","id":"PMC_17431915","title":"Wide phenotypic variations within a family with SALL1 mutations: Isolated external ear abnormalities to Goldenhar syndrome.","date":"2007","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/17431915","citation_count":20,"is_preprint":false},{"pmid":"23152907","id":"PMC_23152907","title":"Structure-function analysis of the glioma targeting NFL-TBS.40-63 peptide corresponding to the tubulin-binding site on the light neurofilament subunit.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23152907","citation_count":20,"is_preprint":false},{"pmid":"33159702","id":"PMC_33159702","title":"SALL1 regulates commitment of odontoblast lineages by interacting with RUNX2 to remodel open chromatin regions.","date":"2020","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/33159702","citation_count":19,"is_preprint":false},{"pmid":"21575694","id":"PMC_21575694","title":"The vimentin-tubulin binding site peptide (Vim-TBS.58-81) crosses the plasma membrane and enters the nuclei of human glioma cells.","date":"2011","source":"International journal of pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/21575694","citation_count":19,"is_preprint":false},{"pmid":"12200128","id":"PMC_12200128","title":"Interaction of the developmental regulator SALL1 with UBE2I and SUMO-1.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12200128","citation_count":18,"is_preprint":false},{"pmid":"18024993","id":"PMC_18024993","title":"Sall1 regulates mitral cell development and olfactory nerve extension in the developing olfactory bulb.","date":"2007","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/18024993","citation_count":17,"is_preprint":false},{"pmid":"28322736","id":"PMC_28322736","title":"sall1 and sall4 repress pou5f3 family expression to allow neural patterning, differentiation, and morphogenesis in Xenopus laevis.","date":"2017","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/28322736","citation_count":17,"is_preprint":false},{"pmid":"35048212","id":"PMC_35048212","title":"Bone mineral density, vitamin D receptor (VDR) gene polymorphisms, fracture risk assessment (FRAX), and trabecular bone score (TBS) in rheumatoid arthritis patients: connecting pieces of the puzzle.","date":"2022","source":"Clinical rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/35048212","citation_count":17,"is_preprint":false},{"pmid":"37722495","id":"PMC_37722495","title":"The use of liposomes functionalized with the NFL-TBS.40-63 peptide as a targeting agent to cross the in vitro blood-brain barrier and target glioblastoma cells.","date":"2023","source":"International journal of pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/37722495","citation_count":17,"is_preprint":false},{"pmid":"35490895","id":"PMC_35490895","title":"LncRNA PART1 inhibits glioma proliferation and migration via miR-374b/SALL1 axis.","date":"2022","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/35490895","citation_count":16,"is_preprint":false},{"pmid":"35567352","id":"PMC_35567352","title":"The zinc finger transcription factor Sall1 is required for the early developmental transition of microglia in mouse embryos.","date":"2022","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/35567352","citation_count":16,"is_preprint":false},{"pmid":"19204018","id":"PMC_19204018","title":"Nephropathy in Townes-Brocks syndrome (SALL1 mutation): imaging and pathological findings in adulthood.","date":"2009","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/19204018","citation_count":16,"is_preprint":false},{"pmid":"27177578","id":"PMC_27177578","title":"The Neurofilament-Derived Peptide NFL-TBS.40-63 Targets Neural Stem Cells and Affects Their Properties.","date":"2016","source":"Stem cells translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27177578","citation_count":15,"is_preprint":false},{"pmid":"29110636","id":"PMC_29110636","title":"Phenotypic and genotypic aspects of Townes-Brock syndrome: case report of patient in southern Brazil with a new SALL1 hotspot region nonsense mutation.","date":"2017","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29110636","citation_count":15,"is_preprint":false},{"pmid":"30421324","id":"PMC_30421324","title":"Trabecular Bone Score (TBS) and Bone Metabolism in Patients Affected with Type 1 Neurofibromatosis (NF1).","date":"2018","source":"Calcified tissue international","url":"https://pubmed.ncbi.nlm.nih.gov/30421324","citation_count":14,"is_preprint":false},{"pmid":"32503328","id":"PMC_32503328","title":"Relationship between Insulin Resistance (HOMA-IR), Trabecular Bone Score (TBS), and Three-Dimensional Dual-Energy X-ray Absorptiometry (3D-DXA) in Non-Diabetic Postmenopausal Women.","date":"2020","source":"Journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32503328","citation_count":14,"is_preprint":false},{"pmid":"29484122","id":"PMC_29484122","title":"SALL1 expression in acute myeloid leukemia.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29484122","citation_count":13,"is_preprint":false},{"pmid":"28759006","id":"PMC_28759006","title":"Re-expression of Sall1 in podocytes protects against adriamycin-induced nephrosis.","date":"2017","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/28759006","citation_count":13,"is_preprint":false},{"pmid":"16892410","id":"PMC_16892410","title":"SALL1 mutations in sporadic Townes-Brocks syndrome are of predominantly paternal origin without obvious paternal age effect.","date":"2006","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/16892410","citation_count":13,"is_preprint":false},{"pmid":"19846929","id":"PMC_19846929","title":"The effect of a novel botanical agent TBS-101 on invasive prostate cancer in animal models.","date":"2009","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19846929","citation_count":13,"is_preprint":false},{"pmid":"21934330","id":"PMC_21934330","title":"Identification and characterization of Sall1-expressing cells present in the adult mouse kidney.","date":"2011","source":"Nephron. Experimental nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/21934330","citation_count":11,"is_preprint":false},{"pmid":"31142767","id":"PMC_31142767","title":"Anephrogenic phenotype induced by SALL1 gene knockout in pigs.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31142767","citation_count":11,"is_preprint":false},{"pmid":"33478437","id":"PMC_33478437","title":"Whole-exome sequencing identified a novel heterozygous mutation of SALL1 and a new homozygous mutation of PTPRQ in a Chinese family with Townes-Brocks syndrome and hearing loss.","date":"2021","source":"BMC medical genomics","url":"https://pubmed.ncbi.nlm.nih.gov/33478437","citation_count":11,"is_preprint":false},{"pmid":"19005989","id":"PMC_19005989","title":"The association of an epibulbar dermoid and Duane syndrome in a patient with a SALL1 mutation (Townes-Brocks Syndrome).","date":"2008","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19005989","citation_count":11,"is_preprint":false},{"pmid":"24896268","id":"PMC_24896268","title":"The NFL-TBS.40-63 anti-glioblastoma peptide disrupts microtubule and mitochondrial networks in the T98G glioma cell line.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24896268","citation_count":10,"is_preprint":false},{"pmid":"19942929","id":"PMC_19942929","title":"Zinc-finger transcriptional factor Sall1 induces angiogenesis by activation of the gene for VEGF-A.","date":"2009","source":"Hypertension research : official journal of the Japanese Society of Hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/19942929","citation_count":10,"is_preprint":false},{"pmid":"29721946","id":"PMC_29721946","title":"Sall1 Regulates Microglial Morphology Cell Autonomously in the Developing Retina.","date":"2018","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/29721946","citation_count":9,"is_preprint":false},{"pmid":"30929925","id":"PMC_30929925","title":"Sall1 plays pivotal roles for lens fiber cell differentiation in mouse.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30929925","citation_count":9,"is_preprint":false},{"pmid":"18280297","id":"PMC_18280297","title":"Two coding single nucleotide polymorphisms in the SALL1 gene in Townes-Brocks syndrome: a case report and review of the literature.","date":"2008","source":"Journal of pediatric surgery","url":"https://pubmed.ncbi.nlm.nih.gov/18280297","citation_count":9,"is_preprint":false},{"pmid":"34257535","id":"PMC_34257535","title":"Hsa_circ_0043265 Restrains Cell Proliferation, Migration and Invasion of Tongue Squamous Cell Carcinoma via Targeting the miR-1243/SALL1 Axis.","date":"2021","source":"Pathology oncology research : POR","url":"https://pubmed.ncbi.nlm.nih.gov/34257535","citation_count":9,"is_preprint":false},{"pmid":"31132447","id":"PMC_31132447","title":"The NFL-TBS.40-63 peptide targets and kills glioblastoma stem cells derived from human patients and also targets nanocapsules into these cells.","date":"2019","source":"International journal of pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/31132447","citation_count":9,"is_preprint":false},{"pmid":"36164551","id":"PMC_36164551","title":"Biological activity of gold nanoparticles combined with the NFL-TBS.40-63 peptide, or with other cell penetrating peptides, on rat glioblastoma cells.","date":"2022","source":"International journal of pharmaceutics: X","url":"https://pubmed.ncbi.nlm.nih.gov/36164551","citation_count":9,"is_preprint":false},{"pmid":"31580873","id":"PMC_31580873","title":"Effects of uninterrupted sinusoidal LF-EMF stimulation on LTP induced by different combinations of TBS/HFS at the Schaffer collateral-CA1 of synapses.","date":"2019","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/31580873","citation_count":9,"is_preprint":false},{"pmid":"37741137","id":"PMC_37741137","title":"SALL1 promotes proliferation and metastasis and activates phosphorylation of p65 and JUN in colorectal cancer cells.","date":"2023","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/37741137","citation_count":8,"is_preprint":false},{"pmid":"31693770","id":"PMC_31693770","title":"miR-4286 promotes prostate cancer progression by targeting the expression of SALL1.","date":"2023","source":"The journal of gene medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31693770","citation_count":8,"is_preprint":false},{"pmid":"10343095","id":"PMC_10343095","title":"Molecular cloning of a SALL1-related pseudogene and mapping to chromosome Xp11.2.","date":"1999","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10343095","citation_count":8,"is_preprint":false},{"pmid":"35567907","id":"PMC_35567907","title":"Ultrasound microbubble-mediated miR-503-5p downregulation suppressed in vitro CRC progression via promoting SALL1 expression.","date":"2022","source":"Tissue & cell","url":"https://pubmed.ncbi.nlm.nih.gov/35567907","citation_count":8,"is_preprint":false},{"pmid":"36177093","id":"PMC_36177093","title":"Characterization and quantification of the interaction between the NFL-TBS.40-63 peptide and lipid nanocapsules.","date":"2022","source":"International journal of pharmaceutics: X","url":"https://pubmed.ncbi.nlm.nih.gov/36177093","citation_count":8,"is_preprint":false},{"pmid":"25862585","id":"PMC_25862585","title":"Neurofilaments and NFL-TBS.40-63 peptide penetrate oligodendrocytes through clathrin-dependent endocytosis to promote their growth and survival in vitro.","date":"2015","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25862585","citation_count":8,"is_preprint":false},{"pmid":"34144141","id":"PMC_34144141","title":"Effect of the NFL-TBS.40-63 peptide on canine glioblastoma cells.","date":"2021","source":"International journal of pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/34144141","citation_count":8,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46913,"output_tokens":7620,"usd":0.12752,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16932,"output_tokens":6874,"usd":0.128255,"stage2_stop_reason":"end_turn"},"total_usd":0.255775,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"SALL1 (also known as HSAL1) encodes a putative C2H2 zinc-finger transcription factor; heterozygous loss-of-function mutations predicted to remove all zinc-finger DNA-binding domains cause Townes-Brocks syndrome, establishing SALL1 as a developmental transcription factor required for normal organogenesis.\",\n      \"method\": \"Genetic sequencing of TBS families; predicted protein truncation analysis\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — identified causative mutations in two independent families with vertical transmission, but molecular mechanism inferred from protein domain prediction rather than direct biochemical assay\",\n      \"pmids\": [\"9425907\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Mouse Sall1 is essential for ureteric bud invasion into the metanephric mesenchyme; homozygous Sall1 deletion results in incomplete ureteric bud outgrowth, failure of tubule formation, and mesenchyme apoptosis, while the mesenchyme retains competence for epithelial differentiation, indicating Sall1 is required for the inductive signaling step rather than downstream differentiation.\",\n      \"method\": \"Targeted gene knockout in mice; histological and in situ hybridization analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean knockout with defined cellular phenotype, replicated in subsequent studies, mechanistically placed Sall1 in mesenchyme-to-ureter inductive signaling\",\n      \"pmids\": [\"11688560\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"SALL1 protein localizes to chromocenters (pericentromeric heterochromatin) and smaller heterochromatin foci in mammalian cells; it partially co-localizes with HP1/M31; it acts as a strong transcriptional repressor in mammalian cells; and it interacts with PIN2/TRF1 (a telomere-repeat-binding factor) via its non-N-terminal domains, as demonstrated by yeast two-hybrid and GST-pulldown.\",\n      \"method\": \"GFP-fusion live/epifluorescence microscopy; transcriptional reporter assay; yeast two-hybrid screen; GST pulldown\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — direct localization by imaging, transcriptional repressor activity by reporter assay, and protein–protein interaction confirmed by two orthogonal methods (Y2H + GST pulldown) in one study\",\n      \"pmids\": [\"11751684\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The N-terminus of mouse Sall1 is sufficient for potent transcriptional repression (>100-fold) and physically interacts with HDAC1, HDAC2, RbAp46/48, MTA-1, and MTA-2 (components of HDAC/chromatin remodeling complexes); HDAC inhibitor trichostatin A partially relieves repression (~3-fold); Sall1 is localized to discrete nuclear foci dependent on the N-terminal repression domain.\",\n      \"method\": \"Luciferase reporter transcriptional repression assay; co-immunoprecipitation with HDAC complex components; deletion analysis; TSA treatment; fluorescence microscopy\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — reconstituted repression activity in vitro, identified interacting complex components by Co-IP, confirmed domain requirements by deletion, multiple orthogonal methods in one study\",\n      \"pmids\": [\"11836251\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"SALL1 interacts with UBE2I (the SUMO E2-conjugating enzyme, human UBC9 homolog) and SUMO-1; SALL1 is covalently modified by at least two SUMO-1 molecules in vitro in the presence of UBA2/AOS1 and UBE2I; mutation of lysine 1086 to arginine abolishes sumoylation, identifying K1086 as the primary SUMO acceptor site.\",\n      \"method\": \"Yeast two-hybrid; GST pulldown; in vitro sumoylation assay; site-directed mutagenesis\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution of SUMOylation with mutagenesis confirmation, validated by two orthogonal interaction methods (Y2H and GST pulldown)\",\n      \"pmids\": [\"12200128\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"A truncated Sall1 protein (lacking zinc fingers 2–10 but retaining the N-terminal repression domain) acts as a dominant-negative or gain-of-function mutant: heterozygous mice expressing truncated Sall1 recapitulate human TBS (hearing loss, renal cystic hypoplasia, wrist bone abnormalities), while Sall1-null mice do not; truncated Sall1 physically interacts with all Sall family members and can mislocalize them.\",\n      \"method\": \"Knock-in mouse model expressing truncated Sall1; co-immunoprecipitation; phenotypic comparison with null allele\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo genetic model with defined phenotype, protein interaction confirmed by Co-IP, mechanistic distinction from null allele established by direct comparison\",\n      \"pmids\": [\"12915476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Sall1 synergistically activates canonical Wnt signaling; this activity depends on its localization to pericentromeric heterochromatin (punctate nuclear foci) but not on direct association with β-catenin; RNAi knockdown of Sall1 reduces Wnt reporter activity; N-terminally truncated Sall1 (as found in TBS) disrupts normal Sall1 heterochromatin localization and reduces Wnt signal enhancement.\",\n      \"method\": \"Luciferase Wnt reporter assay; RNAi knockdown; subcellular localization by fluorescence microscopy; co-immunoprecipitation for β-catenin interaction\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional reporter assay plus RNAi and localization data, but single lab and mechanistic link between heterochromatin localization and Wnt activation is indirect\",\n      \"pmids\": [\"15158448\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"A conserved 12-amino acid motif (RRKQXK-PXXF) in the N-terminus of Sall1 is sufficient to recruit the NuRD (nucleosome remodeling and deacetylase) corepressor complex; endogenous Sall1-NuRD complexes possess HDAC activity; single amino acid substitutions in the motif abolish NuRD binding; the same motif is present in all Sall family members and in Ebfaz, suggesting a general NuRD-recruitment mechanism.\",\n      \"method\": \"Co-immunoprecipitation of endogenous Sall1-NuRD; HDAC activity assay; single amino acid mutagenesis; peptide-based recruitment assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — endogenous complex isolated with enzymatic activity confirmed, motif defined by point mutagenesis, multiple orthogonal methods in one study\",\n      \"pmids\": [\"16707490\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The human SIX1 homeodomain transcription factor directly binds to the SALL1 promoter and transcriptionally activates SALL1 expression during kidney development; co-expression of SIX1 and Eya1 synergistically activates the SALL1 promoter; deletion of the SIX1 binding element significantly reduces promoter responsiveness.\",\n      \"method\": \"Luciferase reporter assay; electrophoretic mobility shift assay (EMSA); chromatin immunoprecipitation; transient transfection\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct DNA binding demonstrated by EMSA and ChIP, functional activation by reporter assay; single lab\",\n      \"pmids\": [\"16670092\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Sall4 and Sall1 form heterodimers; a truncated Sall1 (as produced by TBS mutations) causes mislocalization of Sall4 to heterochromatin, providing a mechanism by which SALL1 truncations can inhibit SALL4 function and potentially explain some TBS symptoms via SALL4 inhibition.\",\n      \"method\": \"Co-immunoprecipitation; fluorescence microscopy of localization; compound Sall4/Sall1 heterozygous mouse phenotyping\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — heterodimer confirmed by Co-IP, mislocalization shown by imaging; single lab\",\n      \"pmids\": [\"16790473\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Sall1 heterochromatin localization is mediated by its C-terminal double zinc finger motifs (7th–10th); a recombinant protein of the most C-terminal double zinc finger (9th–10th) binds specifically to A/T-rich sequences in vitro; Sall1 associates with A/T-rich sequences of major satellite DNA in pericentromeric heterochromatin in vivo.\",\n      \"method\": \"Deletion/mutation analysis of localization by fluorescence microscopy; recombinant protein DNA-binding assay; chromatin immunoprecipitation with major satellite DNA\",\n      \"journal\": \"Genes to cells : devoted to molecular & cellular mechanisms\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro DNA binding with recombinant protein plus in vivo ChIP confirming chromatin association, domain requirements mapped by mutagenesis\",\n      \"pmids\": [\"17295837\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Sall1 directly represses the endogenous target gene Gbx2 in a NuRD-dependent fashion; the Sall1 repression motif is required for this in vivo function; protein kinase C phosphorylates serine 2 of the Sall1 repression motif, and a phosphomimetic mutation at this site disrupts NuRD recruitment and Gbx2 repression in cell culture and Xenopus embryos.\",\n      \"method\": \"Xenopus embryo microinjection with Sall1 mutants; luciferase reporter assay; in vitro PKC phosphorylation assay; phosphomimetic mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vivo embryo validation of NuRD-dependent repression of a native target gene, kinase identified by in vitro assay, phosphomimetic mutagenesis confirms regulatory mechanism; multiple orthogonal methods\",\n      \"pmids\": [\"17895244\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"SALL4 represses transcription of SALL1 through recruitment of the Mi-2/NuRD complex; SALL4 immunocomplexes possess HDAC activity; SALL4 binding sites at the SALL1 promoter are co-occupied by NuRD components; SALL4 overexpression decreases SALL1 mRNA levels in 293T cells.\",\n      \"method\": \"Tandem mass spectrometry identification of SALL4-associated proteins; chromatin immunoprecipitation at SALL1 promoter; qRT-PCR; HDAC activity assay; SALL4 transgenic mouse model\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP confirms SALL4 and NuRD co-occupancy at SALL1 promoter, HDAC activity confirmed, validated in transgenic mice; single lab\",\n      \"pmids\": [\"19440552\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"SALL1 (Sall1) gene transfer induces angiogenesis via transcriptional activation of VEGF-A; Sall1 overexpression increases VEGF-A mRNA and protein levels, and increases VEGF-A promoter activity; neovascularization induced by Sall1 in mouse embryoid bodies is abolished by anti-VEGF antibody; truncated Sall1 does not activate the VEGF-A promoter.\",\n      \"method\": \"Gene transfer in cornea/embryoid body; VEGF-A promoter-luciferase reporter assay; qRT-PCR; ELISA; neutralizing antibody experiment\",\n      \"journal\": \"Hypertension research : official journal of the Japanese Society of Hypertension\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional angiogenesis assay with antibody rescue, promoter reporter assay identifies VEGF-A as direct target; single lab, moderate methods\",\n      \"pmids\": [\"19942929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Sall1 in the metanephric mesenchyme controls ureteric bud tip Wnt patterning: in Sall1 mutants, the stalk marker Wnt9b and β-catenin target Axin2 are ectopically expressed in ureteric bud tips; ureteric bud arrest is rescued by reducing β-catenin levels; ectopic Wnt9b overexpression in the ureteric bud phenocopies the branching defect, placing Sall1 upstream of canonical Wnt signaling at the bud tip.\",\n      \"method\": \"Genetic epistasis in mice; compound mutant rescue by β-catenin heterozygosity; transgenic Wnt9b overexpression; in situ hybridization for marker genes\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with rescue experiment and phenocopy by independent manipulation, establishing pathway position; multiple orthogonal genetic approaches\",\n      \"pmids\": [\"20702564\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Sall1 physically interacts with Nanog and Sox2 in embryonic stem cells; genome-wide ChIP-seq identifies 591 Sall1-bound loci, 80% of which are also Nanog targets; Sall1 positively regulates and synergizes with Nanog for gene transcription; Sall1 overexpression suppresses ectodermal and mesodermal differentiation markers during embryoid body formation.\",\n      \"method\": \"Co-immunoprecipitation; ChIP-seq; overexpression and differentiation assays in ES cells and embryoid bodies\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — protein interaction confirmed by Co-IP, genomic binding by ChIP-seq, functional role in differentiation by overexpression; single lab\",\n      \"pmids\": [\"21062744\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Sall1 acts as both a transcriptional activator and repressor in nephron progenitors: it activates progenitor-specific genes and represses differentiation genes; Sall1 co-occupies many progenitor gene loci together with Six2 and physically binds Six2; however, Sall1 does not bind the Wnt4 locus repressed by Six2, and Sall1-mediated repression is independent of DNA binding at those loci.\",\n      \"method\": \"Conditional Sall1 knockout in Six2+ progenitors; inducible Sall1 deletion; ChIP-seq; co-immunoprecipitation with Six2\",\n      \"journal\": \"Journal of the American Society of Nephrology : JASN\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-seq plus Co-IP plus conditional KO phenotype, multiple orthogonal methods establishing both activator and repressor functions and physical interaction with Six2\",\n      \"pmids\": [\"24744442\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Sall1 maintains nephron progenitor stemness by restraining premature differentiation into renal vesicles; Sall1-mutant progenitors show reduced progenitor gene expression and amplified differentiation gene expression, with ectopic differentiation and depletion of Six2+Cited1+ cap mesenchyme.\",\n      \"method\": \"Conditional Sall1 knockout; transcriptional profiling; immunofluorescence for progenitor markers\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional knockout with defined molecular phenotype by transcriptional profiling and marker analysis; single lab but multiple orthogonal readouts\",\n      \"pmids\": [\"24550112\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Sall1 in renal stromal progenitors non-cell-autonomously restricts expansion of nephron progenitors; Sall1 deletion in Foxd1+ stromal cells causes aberrant nephron progenitor expansion and cystic kidneys; Sall1 protein binds to gene loci including Decorin and Fat4 in stroma, and Decorin (which inhibits BMP-mediated nephron differentiation) is upregulated while Fat4 expression is reduced in mutant stroma.\",\n      \"method\": \"Stromal-specific conditional Sall1 knockout (Foxd1-Cre); ChIP for Decorin and Fat4 loci; gene expression analysis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-type-specific KO establishes non-cell-autonomous function, ChIP identifies direct target loci; single lab\",\n      \"pmids\": [\"26511275\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Sall1 is required for maintaining microglia as resting tissue macrophages; inducible inactivation of Sall1 in vivo converts microglia into inflammatory phagocytes, alters neurogenesis, and disturbs tissue homeostasis; Sall1 is expressed exclusively by microglia and not by other mononuclear phagocytes or CNS-resident cells.\",\n      \"method\": \"Microglia-specific inducible Sall1 knockout mice; flow cytometry; gene expression profiling; neurogenesis assays\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — inducible cell-type-specific KO with defined inflammatory and neurogenic phenotype, replicated across multiple analyses in one study\",\n      \"pmids\": [\"27776109\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Sall1 regulates microglial morphology cell-autonomously; Sall1-deficient microglia shift from ramified to amoeboid morphology in developing retina; this morphological defect is not rescued by wild-type non-microglial cells.\",\n      \"method\": \"Conditional Sall1 knockout (Cx3cr1-Cre); bone marrow transplantation; fluorescence microscopy of microglial morphology\",\n      \"journal\": \"Glia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO plus non-rescue experiment establishing cell autonomy; single lab\",\n      \"pmids\": [\"27459098\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Sall1 is expressed in undifferentiated cardiac progenitor cells (CPCs) giving rise to both ventricles; high Sall1 levels at mesodermal stages enhance cardiomyogenesis, while continued expression suppresses cardiac differentiation, demonstrating a stage-dependent role in regulating CPC fate.\",\n      \"method\": \"Sall1 lineage tracing; in vitro overexpression and loss-of-function in CPCs; differentiation assays\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain- and loss-of-function with differentiation phenotype readout; single lab, moderate method quality from abstract description\",\n      \"pmids\": [\"26876450\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Sall1 interaction with the NuRD complex (via the Sall1 repression motif, SRM) is required for normal renal progenitor differentiation and loop of Henle formation; disruption of Sall1-NuRD in knock-in mice (ΔSRM) causes accelerated nephron progenitor differentiation, bilateral renal hypoplasia, and specific loss of loop of Henle/distal tubule gene expression.\",\n      \"method\": \"Sall1 ΔSRM knock-in mice; transcriptional profiling; immunohistochemistry for nephron segment markers\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo knock-in of interaction-deficient allele with defined molecular and morphological phenotype; establishes Sall1-NuRD interaction as specifically required for loop of Henle formation\",\n      \"pmids\": [\"28760814\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SALL1 functions as a tumor suppressor in breast cancer by recruiting the NuRD complex, which promotes cancer cell senescence; this tumor suppressive function involves the p38 MAPK, ERK1/2, and mTOR signaling pathways; SALL1 knockdown promotes cancer cell growth, proliferation, and colony formation.\",\n      \"method\": \"Gain- and loss-of-function in breast cancer cell lines; in vivo breast tumor models; Co-IP for NuRD recruitment; pathway inhibitor assays\",\n      \"journal\": \"Molecular cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — NuRD recruitment confirmed by Co-IP, pathway involvement by inhibitor studies, in vivo validation; single lab\",\n      \"pmids\": [\"29625565\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Truncated SALL1 (as produced by TBS mutations) interacts with cilia-related factors CCP110 and CEP97 (negative regulators of ciliogenesis) via proximity proteomics; TBS-derived fibroblasts and CRISPR-generated TBS model cells show more frequent cilia formation, altered cilia length and disassembly rates, and aberrant SHH signaling.\",\n      \"method\": \"Proximity proteomics (BioID) with truncated SALL1; CRISPR/Cas9-generated model cell line; cilia formation/length assay; SHH signaling reporter assay; TBS patient fibroblasts\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — proximity proteomics identifies interaction with cilia factors, functional cilia defects confirmed in multiple cell models; single lab\",\n      \"pmids\": [\"29395072\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SALL1 directly regulates commitment of odontoblast lineages by physically interacting with RUNX2 and remodeling open chromatin regions near Tgf-β2 and within the Runx2 locus; Sall1 knockdown inhibits odontoblastic differentiation and decreases chromatin accessibility at odontoblast lineage-related loci.\",\n      \"method\": \"RNA-seq; ATAC-seq; co-immunoprecipitation; proximity ligation assay; siRNA knockdown\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — protein–protein interaction with RUNX2 confirmed by Co-IP and PLA, chromatin remodeling function established by ATAC-seq; single lab\",\n      \"pmids\": [\"33159702\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SALL1 is required for the early developmental transition of embryonic microglia; microglial-specific Sall1 deletion in mice results in prolonged expression of CD206 (normally downregulated between E12.5 and E13.5) and persistence of less-ramified morphology into postnatal stages, establishing SALL1 as a transcriptional regulator of early microglial maturation.\",\n      \"method\": \"Microglial-specific conditional Sall1 knockout; immunofluorescence for CD206 and morphological analysis across developmental stages\",\n      \"journal\": \"Glia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-type-specific conditional KO with defined developmental phenotype; single lab\",\n      \"pmids\": [\"35567352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"SALL1 enforces microglia-specific functions of the TGFβ-SMAD4 signaling axis: SMAD4 directly binds the Sall1 super-enhancer and is required for Sall1 expression in microglia; in turn, SALL1 promotes SMAD4 binding at microglia-specific enhancers while simultaneously suppressing SMAD4 binding at enhancers of genes inappropriately activated in Sall1 enhancer-KO microglia.\",\n      \"method\": \"SALL1 ChIP-seq; Sall1 enhancer knockout mice; SMAD4 ChIP-seq in wild-type and mutant microglia; super-enhancer mapping\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genomic binding studies (ChIP-seq for both SALL1 and SMAD4) in enhancer-KO model, establishing reciprocal functional interaction; multiple orthogonal approaches\",\n      \"pmids\": [\"37322178\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"SALL1 contains two repression domains: one at the extreme N-terminus and one in the central region; SALL1 fragments containing the central repression domain localize to pericentromeric heterochromatin foci in NIH-3T3 cells, suggesting a link between the central repression domain and heterochromatin association.\",\n      \"method\": \"Deletion mapping with transcriptional reporter assay; fluorescence microscopy of GFP-SALL1 fragments in transfected cells\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — deletion analysis maps two repression domains and links central domain to heterochromatin localization; single lab, overlaps with Netzer 2001 findings\",\n      \"pmids\": [\"16443351\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SALL1 is a multi-zinc finger transcriptional repressor that localizes to pericentromeric heterochromatin via its C-terminal zinc fingers (which bind A/T-rich satellite DNA sequences), recruits the NuRD (nucleosome remodeling and deacetylase) corepressor complex through a conserved 12-amino acid N-terminal motif (RRKQXK-PXXF), is subject to PKC-mediated phosphorylation and SUMO modification that modulate its activity, acts as an essential mesenchymal transcription factor during kidney development by controlling ureteric bud induction and nephron progenitor self-renewal, maintains microglial identity by enforcing microglia-specific TGFβ-SMAD4 genomic responses, and its disease-causing truncations act as dominant-negatives by retaining the NuRD-recruitment domain while losing DNA-binding zinc fingers and mislocalizing Sall family heterodimer partners.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SALL1 is a C2H2 multi-zinc-finger transcription factor that governs progenitor cell fate decisions in multiple developmental contexts by coupling sequence-specific chromatin association to corepressor recruitment [#0, #10]. Its C-terminal double zinc fingers (7th–10th) bind A/T-rich major satellite DNA and target the protein to pericentromeric heterochromatin, where it partially co-localizes with HP1 [#2, #10], while a conserved 12-amino-acid N-terminal motif (RRKQXK-PXXF) is sufficient to recruit the NuRD nucleosome-remodeling and deacetylase complex (HDAC1/2, RbAp46/48, MTA1/2), conferring potent transcriptional repression that is partially HDAC-dependent [#3, #7]. SALL1 can act as both repressor and activator depending on context: it directly represses targets such as Gbx2 in a NuRD-dependent manner [#7], yet activates progenitor-specific genes in nephron progenitors [#16]. NuRD recruitment is regulated by PKC phosphorylation of the repression motif, and SALL1 is also SUMOylated at K1086 [#4, #11]. In kidney development, SALL1 is activated downstream of SIX1/Eya1 [#8] and is essential for ureteric bud induction, restraining ectopic Wnt9b/β-catenin signaling at the bud tip, and maintaining Six2+ nephron progenitor self-renewal while restraining premature differentiation—functions that require its physical interaction with Six2 and an intact NuRD-recruitment motif [#1, #14, #16, #22]. In the CNS, SALL1 is expressed exclusively by microglia and maintains their resting, ramified identity by enforcing microglia-specific TGFβ-SMAD4 genomic responses [#19, #27]. Disease-causing truncations that remove the zinc fingers but retain the NuRD-recruitment domain act as dominant-negatives, mislocalizing Sall family heterodimer partners and causing Townes-Brocks syndrome [#0, #5, #9].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Establishing the gene's identity, this work showed that heterozygous truncating SALL1 mutations cause Townes-Brocks syndrome, defining SALL1 as a zinc-finger transcription factor required for organogenesis.\",\n      \"evidence\": \"Genetic sequencing of TBS families with predicted protein truncation analysis\",\n      \"pmids\": [\"9425907\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Mechanism inferred from domain prediction, not biochemical assay\", \"No direct demonstration of dominant-negative vs haploinsufficiency at this stage\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Mouse knockout placed Sall1 in the inductive signaling step of kidney development rather than terminal differentiation, showing it is required for ureteric bud invasion of the metanephric mesenchyme.\",\n      \"evidence\": \"Targeted gene knockout in mice with histology and in situ hybridization\",\n      \"pmids\": [\"11688560\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Molecular targets mediating the inductive signal not identified\", \"Did not address transcriptional mechanism\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Imaging and interaction studies established SALL1 as a heterochromatin-associated transcriptional repressor, linking it to pericentromeric foci and HP1.\",\n      \"evidence\": \"GFP-fusion microscopy, reporter assays, yeast two-hybrid and GST pulldown\",\n      \"pmids\": [\"11751684\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"DNA sequence specificity not defined\", \"PIN2/TRF1 interaction functional consequence unclear\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Biochemistry identified the molecular basis of repression: the N-terminus recruits HDAC/chromatin-remodeling complex components, with HDAC inhibition only partially relieving repression.\",\n      \"evidence\": \"Luciferase repression assays, Co-IP with HDAC complex components, deletion analysis, TSA treatment\",\n      \"pmids\": [\"11836251\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Minimal recruitment motif not yet defined\", \"HDAC-independent repression component unexplained\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Post-translational regulation was established by showing SALL1 is SUMOylated at a defined lysine via UBE2I, adding a modification layer to its activity.\",\n      \"evidence\": \"Yeast two-hybrid, GST pulldown, in vitro SUMOylation assay with K1086R mutagenesis\",\n      \"pmids\": [\"12200128\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Functional consequence of SUMOylation on transcription not shown\", \"In vivo relevance not tested\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"A knock-in model resolved the disease mechanism, demonstrating that truncated Sall1 acts as a dominant-negative/gain-of-function that recapitulates TBS, distinct from the null allele, by binding and mislocalizing Sall family members.\",\n      \"evidence\": \"Truncated Sall1 knock-in mice, Co-IP, phenotypic comparison with null\",\n      \"pmids\": [\"12915476\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Specific mislocalized targets driving each phenotype not isolated\", \"Did not map the heterodimerization interface\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"The repression machinery was pinned to a precise 12-amino-acid motif sufficient to recruit the NuRD complex with intrinsic HDAC activity, defining a general Sall-family NuRD-recruitment mechanism.\",\n      \"evidence\": \"Co-IP of endogenous Sall1-NuRD, HDAC activity assay, single-residue mutagenesis, peptide recruitment\",\n      \"pmids\": [\"16707490\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Genomic loci recruited via this motif not mapped in this study\", \"Regulation of motif activity not addressed\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Upstream regulation was identified, showing SIX1 (with Eya1) directly binds and activates the SALL1 promoter during kidney development.\",\n      \"evidence\": \"Reporter assay, EMSA, ChIP, transient transfection\",\n      \"pmids\": [\"16670092\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Single lab\", \"In vivo requirement of the SIX1 element not tested\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Domain mapping revealed a second, central repression domain that itself localizes to heterochromatin, refining the modular architecture of SALL1.\",\n      \"evidence\": \"Deletion mapping with reporter assay and GFP-fragment microscopy\",\n      \"pmids\": [\"16443351\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Mechanism of central-domain repression undefined\", \"Overlaps with prior localization findings\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"DNA-binding specificity was established, mapping heterochromatin targeting to the C-terminal zinc fingers that bind A/T-rich satellite DNA in vitro and in vivo.\",\n      \"evidence\": \"Deletion/mutation localization analysis, recombinant DNA-binding assay, satellite-DNA ChIP\",\n      \"pmids\": [\"17295837\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Genome-wide euchromatic targets not defined here\", \"Functional role of satellite binding unclear\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"A native target and a regulatory switch were defined: Sall1 represses Gbx2 via NuRD, and PKC phosphorylation of the motif disrupts NuRD recruitment, linking signaling to repression in vivo.\",\n      \"evidence\": \"Xenopus microinjection, reporter assays, in vitro PKC phosphorylation, phosphomimetic mutagenesis\",\n      \"pmids\": [\"17895244\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Physiological stimuli triggering PKC phosphorylation unidentified\", \"Breadth of NuRD-dependent targets unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"A regulatory feedback was revealed: SALL4 represses SALL1 by recruiting NuRD to the SALL1 promoter, embedding SALL1 in a Sall-family cross-regulatory network.\",\n      \"evidence\": \"Mass spectrometry, ChIP at SALL1 promoter, qRT-PCR, HDAC assay, transgenic mice\",\n      \"pmids\": [\"19440552\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Single lab\", \"Physiological context of SALL4-SALL1 repression not established in vivo\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"An activating role in vascular biology was shown, with SALL1 transcriptionally inducing VEGF-A to drive angiogenesis, and truncated SALL1 failing to do so.\",\n      \"evidence\": \"Gene transfer angiogenesis assay, VEGF-A promoter reporter, qRT-PCR/ELISA, neutralizing antibody\",\n      \"pmids\": [\"19942929\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Direct SALL1 binding at VEGF-A promoter not mapped\", \"Single lab\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Wnt-pathway relationships were dissected: early work showed Sall1 enhances canonical Wnt signaling dependent on heterochromatin localization, while genetic epistasis placed Sall1 upstream of Wnt9b/β-catenin at the ureteric bud tip.\",\n      \"evidence\": \"Wnt reporter/RNAi/localization; mouse genetic epistasis with β-catenin rescue and Wnt9b phenocopy\",\n      \"pmids\": [\"15158448\", \"20702564\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Direct transcriptional targets linking Sall1 to Wnt9b regulation not identified\", \"Mechanism connecting heterochromatin localization to Wnt enhancement remains indirect\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"A pluripotency role was identified, showing Sall1 physically associates with Nanog and Sox2 and co-occupies Nanog target loci genome-wide in ES cells.\",\n      \"evidence\": \"Co-IP, ChIP-seq, overexpression/differentiation assays\",\n      \"pmids\": [\"21062744\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Single lab\", \"Whether Sall1 is required (vs sufficient) for pluripotency maintenance not resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"The dual repressor/activator nature of Sall1 in nephron progenitors was established, with co-occupancy and physical interaction with Six2 and DNA-binding-independent repression at key differentiation loci.\",\n      \"evidence\": \"Conditional/inducible KO, ChIP-seq, Co-IP with Six2\",\n      \"pmids\": [\"24744442\", \"24550112\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Mechanism of DNA-binding-independent repression unresolved\", \"How activator vs repressor mode is selected at each locus unclear\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"A non-cell-autonomous function was uncovered, showing stromal Sall1 restricts nephron progenitor expansion through regulation of Decorin and Fat4.\",\n      \"evidence\": \"Foxd1-Cre conditional KO, ChIP at target loci, expression analysis\",\n      \"pmids\": [\"26511275\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Single lab\", \"Direct vs indirect regulation of secreted signals not fully separated\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"A distinct lineage role in the CNS was defined, establishing Sall1 as a microglia-restricted factor required to maintain resting tissue-macrophage identity and morphology.\",\n      \"evidence\": \"Inducible and Cx3cr1-Cre microglial KO, flow cytometry, expression profiling, bone marrow transplant\",\n      \"pmids\": [\"27776109\", \"27459098\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Direct genomic targets in microglia not yet mapped at this stage\", \"Mechanism enforcing identity not defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"A stage-dependent role in cardiac progenitors was shown, where Sall1 levels switch between promoting and suppressing cardiomyogenic differentiation.\",\n      \"evidence\": \"Lineage tracing, gain/loss-of-function differentiation assays in CPCs\",\n      \"pmids\": [\"26876450\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Molecular targets in CPCs unidentified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"The in vivo requirement of NuRD recruitment was isolated, showing the Sall1 repression motif is specifically needed for nephron progenitor differentiation timing and loop of Henle formation.\",\n      \"evidence\": \"ΔSRM knock-in mice, transcriptional profiling, segment-marker IHC\",\n      \"pmids\": [\"28760814\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Genome-wide NuRD-dependent targets in progenitors not enumerated\", \"Why loop of Henle is selectively affected unexplained\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"A tumor-suppressor function was established, with SALL1 recruiting NuRD to promote breast cancer cell senescence through p38/ERK/mTOR signaling.\",\n      \"evidence\": \"Gain/loss-of-function in cell lines, in vivo tumor models, Co-IP, pathway inhibitors\",\n      \"pmids\": [\"29625565\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Single lab\", \"Direct senescence target genes not defined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"A non-transcriptional disease mechanism was identified, showing truncated SALL1 interacts with ciliogenesis regulators CCP110/CEP97 and perturbs cilia and SHH signaling in TBS models.\",\n      \"evidence\": \"BioID proximity proteomics, CRISPR model cells, cilia/SHH assays, patient fibroblasts\",\n      \"pmids\": [\"29395072\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Single lab\", \"Whether full-length SALL1 normally regulates cilia unclear\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"A chromatin-remodeling role in odontoblast commitment was shown, with SALL1 binding RUNX2 and modulating accessibility near Tgf-β2 and the Runx2 locus.\",\n      \"evidence\": \"RNA-seq, ATAC-seq, Co-IP, proximity ligation, siRNA knockdown\",\n      \"pmids\": [\"33159702\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Single lab\", \"Direct vs indirect chromatin effects not separated\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"An early microglial developmental role was defined, showing Sall1 drives the embryonic maturation transition marked by CD206 downregulation and ramification.\",\n      \"evidence\": \"Microglial conditional KO, CD206 immunofluorescence, morphology across stages\",\n      \"pmids\": [\"35567352\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Direct transcriptional targets of the maturation program unidentified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"The microglial identity mechanism was resolved, showing reciprocal control where SMAD4 activates the Sall1 super-enhancer and SALL1 in turn directs SMAD4 to microglia-specific enhancers while blocking inappropriate ones.\",\n      \"evidence\": \"SALL1 and SMAD4 ChIP-seq in enhancer-KO mice, super-enhancer mapping\",\n      \"pmids\": [\"37322178\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Whether NuRD mediates the SMAD4 redistribution not tested\", \"Structural basis of SALL1-SMAD4 cooperation unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How SALL1 selects between transcriptional activation and NuRD-dependent repression at individual loci, and how its DNA-binding-independent repression operates, remain unresolved across its developmental and immune contexts.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"No unified model for activator-vs-repressor mode selection\", \"Mechanism of DNA-binding-independent repression undefined\", \"Structural basis of partner heterodimerization unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 2, 3, 16]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 3]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [2, 10]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [3, 28]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [3, 7, 16]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [7, 25]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [1, 14, 16, 22]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [14, 27]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [19, 27]}\n    ],\n    \"complexes\": [\"NuRD complex\"],\n    \"partners\": [\"HDAC1\", \"HDAC2\", \"MTA1\", \"MTA2\", \"SIX2\", \"SMAD4\", \"RUNX2\", \"UBE2I\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}